Back to Agenda
Regulatory Affairs: Part 6: Interactions with FDA
Session Chair(s)
Carol H. Danielson, DrPH, MS, RAC
President
Regulatory Advantage, LLC, United States
Kevin Daniel Healy, PhD
Senior Vice President Regulatory Affairs
Entrada Therapeutics, United States
Regulatory Affairs: Part 6: Interactions with FDA
Have an account?